首页 > 市场调查报告书 > 製药

OTC 非处方药

市场调查报告书

商品编码

1548104

全球尼古丁替代疗法市场研究报告 - 2024 年至 2032 年行业分析、规模、份额、成长、趋势和预测

Global Nicotine Replacement Therapy Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年07月01日 | 出版商:

Value Market Research | 英文 128 Pages | 商品交期: 最快1-2个工作天内

价格

简介目录图表

全球尼古丁替代疗法市场需求预计将从 2023 年的 703.1 亿美元达到近 2,935.8 亿美元的市场规模，2024-2032 年研究期间复合年增长率为 17.21%。

尼古丁替代疗法（NRT）是 FDA 批准的第一种用于戒烟的药物。尼古丁替代疗法旨在减少尝试戒烟期间经常出现的戒断症状，从而增加保持戒烟的可能性。尼古丁口香糖是第一个在 80 年代初推出的产品，随后在 90 年代初推出尼古丁贴片，几年后这两种产品都成为非处方药 (OTC)。然后透过处方引入了尼古丁鼻喷雾剂，在同年又推出了尼古丁吸入器，现在这两种产品都可以在柜檯购买。尼古丁长片/片剂被推出，后来，它们以药丸或糖果状片剂的形式出现，也有非处方药可供选择。任何人都可以在药房、药局和超市购买所有这些交付形式。

市场动态

NRT 市场的推动因素包括日益增长的戒烟愿望、越来越多的製造商提供反吸烟活动以及戒烟产品的普及。其他因素，例如慢性阻塞性肺病（COPD）、气喘、肺癌、气喘、各种心臟和呼吸系统疾病病例的增加，以及对吸烟负面影响的认识不断提高，也将支持预测期内的市场扩张。

该报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。

此外，这些工具还对全球尼古丁替代疗法市场中的每个应用/产品领域进行了包容性评估。

市场区隔

整个尼古丁替代疗法市场已细分为产品类型和配销通路。该报告根据地理细分对这些子集进行了分析。这项研究将使行销人员了解情况，并有助于确定产品或服务的目标族群。

按产品分类

尼古丁替代疗法（吸入器、口香糖、透皮贴片、舌下片、含片、其他）
电子烟
加热不燃烧烟草製品

按配销通路

在线的
离线
区域分析

本节涵盖区域细分，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲尼古丁替代疗法市场当前和未来的需求。此外，该报告重点关注所有主要地区对个别应用领域的需求。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。尼古丁替代疗法市场的主要参与者包括 Cipla Inc.、辉瑞、Glenmark Pharmaceuticals Ltd.、Fertin Pharma、Philip Morris Products SA、英美烟草公司、日本烟草公司、帝国品牌公司、强生私人有限公司。本节包括竞争格局的整体视图，包括各种策略发展，例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

区域展望
介绍
北美销售分析
- 概览、历史与预测资料销售分析
- 北美按细分市场销售分析
- 北美按国家销售分析
- 美国销售分析
- 加拿大销售分析
- 墨西哥销售分析
欧洲销售分析
- 概览、历史与预测资料销售分析
- 欧洲按细分市场销售分析
- 欧洲按国家销售分析
- 英国销售分析
- 法国销售分析
- 德国销售分析
- 义大利销售分析
- 俄罗斯销售分析
- 欧洲其他地区销售分析
亚太地区销售分析
- 概览、历史与预测资料销售分析
- 亚太地区按细分市场销售分析
- 亚太地区按国家销售分析
- 中国销售分析
- 印度销售分析
- 日本销售分析
- 韩国销售分析
- 澳洲销售分析
- 东南亚销售分析
- 亚太地区其他地区销售分析
拉丁美洲销售分析
- 概览、历史与预测资料销售分析
- 拉丁美洲按细分市场销售分析
- 拉丁美洲按国家销售分析
- 巴西销售分析
- 阿根廷销售分析
- 秘鲁销售分析
- 智利销售分析
- 拉丁美洲其他地区销售分析
中东和非洲销售分析
- 概览、历史与预测资料销售分析
- 中东和非洲按细分市场销售分析
- 中东和非洲按国家销售分析
- 沙乌地阿拉伯销售分析
- 阿联酋销售分析
- 以色列销售分析
- 南非销售分析
- 中东其他地区和非洲销售分析

第 8 章：尼古丁替代疗法公司的竞争格局

尼古丁替代疗法市场竞争
伙伴关係/协作/协议
併购
新产品发布
其他发展

第 9 章：公司简介

顶级公司市占率分析
市场集中度
Cipla Inc.

公司概况
公司收入
产品
最新动态

Pfizer Inc.

公司概况
公司收入
产品
最新动态

Glenmark Pharmaceuticals Ltd.

公司概况
公司收入
产品
最新动态

Fertin Pharma

公司概况
公司收入
产品
最新动态

Philip Morris Products SA

公司概况
公司收入
产品
最新动态

British American Tobacco Plc

公司概况
公司收入
产品
最新动态

Japan Tobacco Inc.

公司概况
公司收入
产品
最新动态

Imperial Brands Plc

公司概况
公司收入
产品
最新动态

Johnson & Johnson Private Limited

公司概况
公司收入
产品
最新动态

註 - 在公司概况中，财务详细资讯和最新发展视情况而定，或对私人公司而言可能不包括在内

简介目录图表

Product Code: VMR11211481

The global demand for Nicotine Replacement Therapy Market is presumed to reach the market size of nearly USD 293.58 Billion by 2032 from USD 70.31 Billion in 2023 with a CAGR of 17.21% under the study period 2024 - 2032.

Nicotine replacement therapy (NRT) is the first pharmacological drug that was approved by the FDA for smoking cessation. Nicotine replacement therapy aims to reduce withdrawal symptoms which are often experienced during an attempt to quit smoking and thus increase the probability of remaining abstinent. Nicotine gums were the first product that was introduced in the early '80s followed by the nicotine patch in the early '90s and both became available over the counter (OTC) after few years. Then nicotine nasal spray was introduced by prescription, followed by the nicotine inhaler in the same year and now both them are available over the counter. Nicotine longezes/tablets were introduced, later on, they come in pill or candy-like tablet and are also available OTC. All these forms of delivery can be purchased by anyone at pharmacies, drug stores, and supermarkets.

Market Dynamics

The market of NRT is driven by the growing desire to quit smoking and the rising number of manufacturers offering anti-smoking campaigns and penetration of smoking cessation products. Other factors like growing cases of chronic obstructive pulmonary disease (COPD), asthma, lung cancer, asthma, various cardiac and respiratory disease coupled with rising awareness regarding negative effects of smoking is also set to support the market expansion over the forecast period.

The report covers Porter's Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level.

Additionally, these tools also give inclusive assessment of each application/product segment in the global market of nicotine replacement therapy.

Market Segmentation

The entire nicotine replacement therapy market has been sub-categorized into product type and distribution channel. The report provides an analysis of these subsets with respect to the geographical segmentation. This research study will keep marketer informed and helps to identify the target demographics for a product or service.

By Product

Nicotine Replacement Therapy (Inhalers, Gum, Transdermal Patches, Sublingual Tablets, Lozenges, Others)
E-cigarettes
Heat-not-burn Tobacco Products

By Distribution Channel

Online
Offline
Regional Analysis

This section covers regional segmentation which accentuates on current and future demand for nicotine replacement therapy market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Nicotine Replacement Therapy market include Cipla Inc., Pfizer Inc., Glenmark Pharmaceuticals Ltd., Fertin Pharma, Philip Morris Products S.A., British American Tobacco plc, Japan Tobacco Inc., Imperial Brands plc, Johnson & Johnson Private Limited. This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. NICOTINE REPLACEMENT THERAPY - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product
- 3.7.2 Market Attractiveness Analysis By Distribution Channel
- 3.7.3 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL NICOTINE REPLACEMENT THERAPY MARKET ANALYSIS BY PRODUCT

5.1. Overview By Product
5.2. Historical and Forecast Data
5.3. Analysis By Product
5.4. Nicotine Replacement Therapy (Inhalers, Gum, Transdermal Patches, Sublingual Tablets, Lozenges, Others) Historic and Forecast Sales By Regions
5.5. E-cigarettes Historic and Forecast Sales By Regions
5.6. Heat-not-burn tobacco products Historic and Forecast Sales By Regions

6. GLOBAL NICOTINE REPLACEMENT THERAPY MARKET ANALYSIS BY DISTRIBUTION CHANNEL

6.1. Overview By Distribution Channel
6.2. Historical and Forecast Data
6.3. Analysis By Distribution Channel
6.4. Online Historic and Forecast Sales By Regions
6.5. Offline Historic and Forecast Sales By Regions

7. GLOBAL NICOTINE REPLACEMENT THERAPY MARKET ANALYSIS BY GEOGRAPHY

7.1. Regional Outlook
7.2. Introduction
7.3. North America Sales Analysis
- 7.3.1 Overview, Historic and Forecast Data Sales Analysis
- 7.3.2 North America By Segment Sales Analysis
- 7.3.3 North America By Country Sales Analysis
- 7.3.4 United States Sales Analysis
- 7.3.5 Canada Sales Analysis
- 7.3.6 Mexico Sales Analysis
7.4. Europe Sales Analysis
- 7.4.1 Overview, Historic and Forecast Data Sales Analysis
- 7.4.2 Europe By Segment Sales Analysis
- 7.4.3 Europe By Country Sales Analysis
- 7.4.4 United Kingdom Sales Analysis
- 7.4.5 France Sales Analysis
- 7.4.6 Germany Sales Analysis
- 7.4.7 Italy Sales Analysis
- 7.4.8 Russia Sales Analysis
- 7.4.9 Rest Of Europe Sales Analysis
7.5. Asia Pacific Sales Analysis
- 7.5.1 Overview, Historic and Forecast Data Sales Analysis
- 7.5.2 Asia Pacific By Segment Sales Analysis
- 7.5.3 Asia Pacific By Country Sales Analysis
- 7.5.4 China Sales Analysis
- 7.5.5 India Sales Analysis
- 7.5.6 Japan Sales Analysis
- 7.5.7 South Korea Sales Analysis
- 7.5.8 Australia Sales Analysis
- 7.5.9 South East Asia Sales Analysis
- 7.5.10 Rest Of Asia Pacific Sales Analysis
7.6. Latin America Sales Analysis
- 7.6.1 Overview, Historic and Forecast Data Sales Analysis
- 7.6.2 Latin America By Segment Sales Analysis
- 7.6.3 Latin America By Country Sales Analysis
- 7.6.4 Brazil Sales Analysis
- 7.6.5 Argentina Sales Analysis
- 7.6.6 Peru Sales Analysis
- 7.6.7 Chile Sales Analysis
- 7.6.8 Rest of Latin America Sales Analysis
7.7. Middle East & Africa Sales Analysis
- 7.7.1 Overview, Historic and Forecast Data Sales Analysis
- 7.7.2 Middle East & Africa By Segment Sales Analysis
- 7.7.3 Middle East & Africa By Country Sales Analysis
- 7.7.4 Saudi Arabia Sales Analysis
- 7.7.5 UAE Sales Analysis
- 7.7.6 Israel Sales Analysis
- 7.7.7 South Africa Sales Analysis
- 7.7.8 Rest Of Middle East And Africa Sales Analysis

8. COMPETITIVE LANDSCAPE OF THE NICOTINE REPLACEMENT THERAPY COMPANIES

8.1. Nicotine Replacement Therapy Market Competition
8.2. Partnership/Collaboration/Agreement
8.3. Merger And Acquisitions
8.4. New Product Launch
8.5. Other Developments

9. COMPANY PROFILES OF NICOTINE REPLACEMENT THERAPY INDUSTRY

9.1. Top Companies Market Share Analysis
9.2. Market Concentration Rate
9.3. Cipla Inc.
- 9.3.1 Company Overview
- 9.3.2 Company Revenue
- 9.3.3 Products
- 9.3.4 Recent Developments
9.4. Pfizer Inc.
- 9.4.1 Company Overview
- 9.4.2 Company Revenue
- 9.4.3 Products
- 9.4.4 Recent Developments
9.5. Glenmark Pharmaceuticals Ltd.
- 9.5.1 Company Overview
- 9.5.2 Company Revenue
- 9.5.3 Products
- 9.5.4 Recent Developments
9.6. Fertin Pharma
- 9.6.1 Company Overview
- 9.6.2 Company Revenue
- 9.6.3 Products
- 9.6.4 Recent Developments
9.7. Philip Morris Products S.A.
- 9.7.1 Company Overview
- 9.7.2 Company Revenue
- 9.7.3 Products
- 9.7.4 Recent Developments
9.8. British American Tobacco Plc
- 9.8.1 Company Overview
- 9.8.2 Company Revenue
- 9.8.3 Products
- 9.8.4 Recent Developments
9.9. Japan Tobacco Inc.
- 9.9.1 Company Overview
- 9.9.2 Company Revenue
- 9.9.3 Products
- 9.9.4 Recent Developments
9.10. Imperial Brands Plc
- 9.10.1 Company Overview
- 9.10.2 Company Revenue
- 9.10.3 Products
- 9.10.4 Recent Developments
9.11. Johnson & Johnson Private Limited
- 9.11.1 Company Overview
- 9.11.2 Company Revenue
- 9.11.3 Products
- 9.11.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

简介目录图表

LIST OF TABLES

Market Snapshot
Drivers: Impact Analysis
Restraints: Impact Analysis
List of Raw Material
List of Raw Material Manufactures
Analysis By Product (USD MN)
Nicotine Replacement Therapy (Inhalers, Gum, Transdermal Patches, Sublingual Tablets, Lozenges, Others) Market Sales By Geography (USD MN)
E-cigarettes Market Sales By Geography (USD MN)
Heat-not-burn tobacco products Market Sales By Geography (USD MN)
Analysis By Distribution Channel (USD MN)
Online Market Sales By Geography (USD MN)
Offline Market Sales By Geography (USD MN)
Global Nicotine Replacement Therapy Market Sales By Geography (USD MN)
North America Market Analysis (USD MN)
United States Market Analysis (USD MN)
Canada Market Analysis (USD MN)
Mexico Market Analysis (USD MN)
Europe Market Analysis (USD MN)
Europe Market Estimate By Country (USD MN)
United Kingdom Market Analysis (USD MN)
France Market Analysis (USD MN)
Germany Market Analysis (USD MN)
Italy Market Analysis (USD MN)
Russia Market Analysis (USD MN)
Spain Market Analysis (USD MN)
Rest of Europe Market Analysis (USD MN)
Asia Pacific Market Analysis (USD MN)
China Market Analysis (USD MN)
Japan Market Analysis (USD MN)
India Market Analysis (USD MN)
South Korea Market Analysis (USD MN)
Australia Market Analysis (USD MN)
South East Asia Market Analysis (USD MN)
Rest of Asia Pacific Market Analysis (USD MN)
Latin America Market Analysis (USD MN)
Brazil Market Analysis (USD MN)
Argentina Market Analysis (USD MN)
Peru Market Analysis (USD MN)
Chile Market Analysis (USD MN)
Rest of Latin America Market Analysis (USD MN)
Middle East & Africa Market Analysis (USD MN)
Saudi Arabia Market Analysis (USD MN)
UAE Market Analysis (USD MN)
Israel Market Analysis (USD MN)
South Africa Market Analysis (USD MN)
Rest of Middle East and Africa Market Analysis (USD MN)
Partnership/Collaboration/Agreement
Mergers And Acquisition

LIST OF FIGURES

Research Scope of Nicotine Replacement Therapy Report
Market Research Process
Market Research Methodology
Global Nicotine Replacement Therapy Market Size, By Region (USD MN)
Porters Five Forces Analysis
Market Attractiveness Analysis By Product
Market Attractiveness Analysis By Distribution Channel
Market Attractiveness Analysis By Region
Value Chain Analysis
Global Market Analysis By Product (USD MN)
Nicotine Replacement Therapy (Inhalers, Gum, Transdermal Patches, Sublingual Tablets, Lozenges, Others) Market Sales By Geography (USD MN)
E-cigarettes Market Sales By Geography (USD MN)
Heat-not-burn tobacco products Market Sales By Geography (USD MN)
Global Market Analysis By Distribution Channel (USD MN)
Online Market Sales By Geography (USD MN)
Offline Market Sales By Geography (USD MN)
Global Market Sales (USD MN)
North America Market Sales (USD MN)
Europe Market Sales (USD MN)
Asia Pacific Market Sales (USD MN)
Latin America Market Sales (USD MN)
Middle East & Africa Market Sales (USD MN)
Recent Development in Industry
Top Company Market Share Analysis